Truist Financial Raises Celsius (NASDAQ:CELH) Price Target to $65.00

Key Points

• Truist Financial has increased the price target for Celsius Holdings (NASDAQ:CELH) from $55.00 to $65.00, indicating a potential upside of 21.27% from the current price.
• Several other research firms have also raised their targets for Celsius, with increases from $44.00 to $54.00 by JPMorgan Chase and from $50.00 to $56.00 by Stifel Nicolaus, among others.
• Celsius recently reported $739.30 million in revenue for the quarter, a significant year-over-year increase of 83.9%, and earnings per share of $0.47, exceeding expectations.

Celsius (NASDAQ:CELH - Get Free Report) had its price target lifted by research analysts at Truist Financial from $55.00 to $65.00 in a research report issued on Monday, Marketbeat.com reports. The brokerage presently has a "buy" rating on the stock. Truist Financial's price objective points to a potential upside of 18.79% from the company's current price.

A number of other research firms also recently issued reports on CELH. Maxim Group lifted their price objective on Celsius from $50.00 to $65.00 and gave the stock a "buy" rating in a research note on Friday, August 8th. Morgan Stanley boosted their price target on shares of Celsius from $42.00 to $56.00 and gave the stock an "equal weight" rating in a research report on Friday, August 8th. Wells Fargo & Company upped their price target on shares of Celsius from $44.00 to $45.00 and gave the company an "overweight" rating in a research note on Wednesday, June 4th. Bank of America lifted their price objective on shares of Celsius from $35.00 to $40.00 and gave the stock an "underperform" rating in a research note on Friday, August 8th. Finally, Roth Capital restated a "buy" rating and issued a $52.00 target price (up from $46.00) on shares of Celsius in a report on Thursday, June 26th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and sixteen have assigned a buy rating to the stock. Based on data from MarketBeat, Celsius has a consensus rating of "Moderate Buy" and a consensus price target of $52.28.

Celsius Stock Performance

Shares of NASDAQ CELH opened at $54.72 on Monday. The company has a market cap of $14.10 billion, a P/E ratio of 147.89, a P/E/G ratio of 1.65 and a beta of 1.40. Celsius has a 52-week low of $21.10 and a 52-week high of $55.87. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 2.11. The firm's fifty day moving average is $45.14 and its two-hundred day moving average is $36.53.

Celsius (NASDAQ:CELH - Get Free Report) last issued its quarterly earnings data on Thursday, August 7th. The company reported $0.47 earnings per share for the quarter, beating analysts' consensus estimates of $0.23 by $0.24. Celsius had a return on equity of 36.88% and a net margin of 7.91%. The firm had revenue of $739.30 million during the quarter, compared to analyst estimates of $632.13 million. During the same quarter last year, the business posted $0.28 earnings per share. The business's quarterly revenue was up 83.9% compared to the same quarter last year. As a group, analysts anticipate that Celsius will post 0.89 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, CFO Jarrod Langhans sold 5,000 shares of the stock in a transaction that occurred on Thursday, August 7th. The stock was sold at an average price of $51.18, for a total transaction of $255,900.00. Following the transaction, the chief financial officer owned 109,227 shares in the company, valued at $5,590,237.86. This trade represents a 4.38% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO John Fieldly sold 143,167 shares of the company's stock in a transaction on Thursday, August 7th. The stock was sold at an average price of $51.18, for a total transaction of $7,327,287.06. Following the transaction, the chief executive officer owned 895,410 shares of the company's stock, valued at $45,827,083.80. This represents a 13.78% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 1,111,141 shares of company stock worth $52,241,605 in the last 90 days. 2.20% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the stock. Westside Investment Management Inc. purchased a new stake in Celsius during the 1st quarter worth approximately $32,000. Summit Securities Group LLC purchased a new stake in shares of Celsius during the first quarter worth approximately $34,000. MassMutual Private Wealth & Trust FSB raised its stake in Celsius by 255.1% in the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 1,044 shares of the company's stock valued at $37,000 after purchasing an additional 750 shares during the last quarter. Hantz Financial Services Inc. lifted its holdings in Celsius by 1,476.0% in the 2nd quarter. Hantz Financial Services Inc. now owns 788 shares of the company's stock valued at $37,000 after purchasing an additional 738 shares in the last quarter. Finally, UMB Bank n.a. lifted its holdings in Celsius by 145.0% in the 1st quarter. UMB Bank n.a. now owns 1,426 shares of the company's stock valued at $51,000 after purchasing an additional 844 shares in the last quarter. Institutional investors and hedge funds own 60.95% of the company's stock.

About Celsius

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.